Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Long-Term Investments (2020 - 2024)

United Health Products (UEEC) has disclosed Long-Term Investments for 5 consecutive years, with $25.3 million as the latest value for Q2 2024.

  • On a quarterly basis, Long-Term Investments changed 0.0% to $25.3 million in Q2 2024 year-over-year; TTM through Jun 2024 was $25.3 million, a 0.0% change, with the full-year FY2022 number at $25.3 million, down 6.31% from a year prior.
  • Long-Term Investments was $25.3 million for Q2 2024 at United Health Products, roughly flat from $25.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $27.0 million in Q4 2021 to a low of $43120.0 in Q4 2020.
  • A 5-year average of $20.3 million and a median of $25.3 million in 2022 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 62555.84% in 2021, then dropped 6.31% in 2022.
  • United Health Products' Long-Term Investments stood at $43120.0 in 2020, then skyrocketed by 62555.84% to $27.0 million in 2021, then fell by 6.31% to $25.3 million in 2022, then changed by 0.0% to $25.3 million in 2023, then changed by 0.0% to $25.3 million in 2024.
  • Per Business Quant, the three most recent readings for UEEC's Long-Term Investments are $25.3 million (Q2 2024), $25.3 million (Q1 2024), and $25.3 million (Q3 2023).